Mario Cazzola, MD
Postgraduate School of Respiratory Medicine,University of Rome ‘Tor Vergata’, Rome, Italy
Mario Cazzola is a Professor of Respiratory Medicine and Director of the Postgraduate School of Respiratory Medicine at the University of Rome ‘Tor Vergata’, Rome, Italy, where he is also Chief of the Respiratory Clinical Pharmacology Unit. He is Honorary Professor at the Sackler Institute of Pulmonary Pharmacology, GKT School of Biomedical Sciences, London, UK.
He is the author or co-author of almost 500 scientific papers.
He founded Therapeutic Advances in Respiratory Diseases and served as its first Editor-in-chief. He is serving as the Editor-in-Chief for Pulmonary Pharmacology & Therapeutics, an Associate Editor for Respiratory Medicine, for Respiratory Research, and for Clinical Investigation, and a Section Editor for The Open Respiratory Medicine Journal.
He was the Chairman of the Airway Pharmacology and Treatment Group, the Secretary of the Inflammatory Airway Diseases and Clinical Allergy Assembly and the Postgraduate Courses Director at the European Respiratory Society. He was the Co-chairman of the European Respiratory Society/American Thoracic Society Task Force "Outcomes for COPD pharmacological trials: from lung function to biomarkers". He is a member of the steering committee of the Airway Disorders Network and is serving as Governor of the Italian Chapter at the American College of Chest Physicians. He is the Chairman of the Southern Europe Chapter at Interasma, and the Chair of the Med COPD Forum.